130 related articles for article (PubMed ID: 11762554)
1. P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients.
Donnenberg VS; Burckart GJ; Griffith BP; Jain AB; Zeevi A; Berg AD
J Clin Pharmacol; 2001 Dec; 41(12):1271-9. PubMed ID: 11762554
[TBL] [Abstract][Full Text] [Related]
2. Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans.
Aggarwal S; Tsuruo T; Gupta S
J Clin Immunol; 1997 Nov; 17(6):448-54. PubMed ID: 9418184
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein activity is decreased in CD4+ but not CD8+ lung allograft-infiltrating T cells during acute cellular rejection.
Donnenberg VS; Burckart GJ; Zeevi A; Griffith BP; Iacono A; McCurry KR; Wilson JW; Donnenberg AD
Transplantation; 2004 Jun; 77(11):1699-706. PubMed ID: 15201669
[TBL] [Abstract][Full Text] [Related]
4. Differential activity of P-glycoprotein in normal blood lymphocyte subsets.
Ludescher C; Pall G; Irschick EU; Gastl G
Br J Haematol; 1998 Jun; 101(4):722-7. PubMed ID: 9674746
[TBL] [Abstract][Full Text] [Related]
5. Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell function.
Llaudó I; Cassis L; Torras J; Bestard O; Franquesa Ml; Cruzado JM; Cerezo G; Castaño E; Pétriz J; Herrero-Fresneda I; Grinyó JM; Lloberas N
J Pharm Pharm Sci; 2012; 15(3):407-19. PubMed ID: 22974789
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection.
Andreana A; Aggarwal S; Gollapudi S; Wien D; Tsuruo T; Gupta S
AIDS Res Hum Retroviruses; 1996 Oct; 12(15):1457-62. PubMed ID: 8893053
[TBL] [Abstract][Full Text] [Related]
7. Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets.
Donnenberg VS; Wilson JW; Burckart GJ; Zeevi A; Iacono A; Donnenberg AD
Cytometry A; 2004 Feb; 57(2):75-85. PubMed ID: 14750128
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein functions in peripheral-blood CD4+ cells of patients with systemic lupus erythematosus.
Henmi K; Yoshida M; Yoshikawa N; Hirano T
Biol Pharm Bull; 2008 May; 31(5):873-8. PubMed ID: 18451510
[TBL] [Abstract][Full Text] [Related]
9. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation.
Parasrampuria DA; Lantz MV; Birnbaum JL; Vincenti FG; Benet LZ
J Clin Pharmacol; 2002 Mar; 42(3):304-11. PubMed ID: 11865967
[TBL] [Abstract][Full Text] [Related]
10. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Lucia MB; Rutella S; Leone G; Vella S; Cauda R
J Acquir Immune Defic Syndr; 2001 Aug; 27(4):321-30. PubMed ID: 11468419
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function.
Bommhardt U; Cerottini JC; MacDonald HR
Eur J Immunol; 1994 Dec; 24(12):2974-81. PubMed ID: 7805724
[TBL] [Abstract][Full Text] [Related]
12. Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging.
Pilarski LM; Paine D; McElhaney JE; Cass CE; Belch AR
Am J Hematol; 1995 Aug; 49(4):323-35. PubMed ID: 7639278
[TBL] [Abstract][Full Text] [Related]
13. An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates.
Vasquez EM; Petrenko Y; Jacobssen V; Sifontis NM; Testa G; Sankary H; Benedetti E
Transplant Proc; 2005; 37(1):175-7. PubMed ID: 15808585
[TBL] [Abstract][Full Text] [Related]
14. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.
Hegewisch-Becker S; Staib F; Löning T; Pichlmeier U; Kröger N; Reymann A; Hossfeld DK
Ann Oncol; 1998 Jan; 9(1):85-93. PubMed ID: 9541688
[TBL] [Abstract][Full Text] [Related]
15. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies.
Beck J; Gekeler V; Ringger M; Handgretinger R; Niethammer D
Cancer Lett; 1996 Feb; 99(2):197-207. PubMed ID: 8616825
[TBL] [Abstract][Full Text] [Related]
16. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
Macedo C; Donnenberg A; Popescu I; Reyes J; Abu-Elmagd K; Shapiro R; Zeevi A; Fung JJ; Storkus WJ; Metes D
Transpl Immunol; 2005 Jun; 14(2):109-16. PubMed ID: 15935301
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood T lymphocyte subsets in children with congenital asplenia.
Motkowski R; Michalkiewicz J; Mikoluc B; Smolka-Afifi D; Pietrucha B; Kubiszewska I; Piotrowska-Jastrzebska J; Bernatowska E
Hum Immunol; 2012 Nov; 73(11):1091-7. PubMed ID: 22902394
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of P-glycoprotein in cord blood and peripheral blood lymphocyte subpopulations.
Aggarwal S; Gupta A; Tsuruo T; Gupta S
Int J Oncol; 1996 Jun; 8(6):1063-8. PubMed ID: 21544465
[TBL] [Abstract][Full Text] [Related]
19. Loss of CD31 receptor in CD4+ and CD8+ T-cell subsets in children with primary hypertension is associated with hypertension severity and hypertensive target organ damage.
Gackowska L; Michałkiewicz J; Niemirska A; Helmin-Basa A; Kłosowski M; Kubiszewska I; Obrycki Ł; Szalecki M; Wierzbicka A; Kułaga Z; Wiese M; Litwin M
J Hypertens; 2018 Nov; 36(11):2148-2156. PubMed ID: 29965884
[TBL] [Abstract][Full Text] [Related]
20. A simplified approach to determining P-glycoprotein expression in peripheral blood mononuclear cell subsets.
Ford J; Hoggard PG; Owen A; Khoo SH; Back DJ
J Immunol Methods; 2003 Mar; 274(1-2):129-37. PubMed ID: 12609539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
